Association of tocolytic therapy with antenatal steroid administration and infant outcomes

American Journal of Perinatology

Volumn 15, Issue 2, 1998, Pages 87-92

  Palta, Mari ^a,d   Sadek, Mona ^a   Lim, Tjen Sien ^b   Evans, Michael ^a   McGuinness, Gail ^c  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b University of Wisconsin Madison   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d NONE   (United States)

Author keywords

Corticosteroids; Neonatal outcomes; Tocolytics

Indexed keywords

MAGNESIUM SULFATE; STEROID; TERBUTALINE; UTERUS SPASMOLYTIC AGENT;

ARTICLE; BRAIN HEMORRHAGE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; NEWBORN MORTALITY; PREGNANCY COMPLICATION; PREMATURE LABOR; PRIORITY JOURNAL; STEROID THERAPY; TOCOLYSIS; TREATMENT OUTCOME; VERY LOW BIRTH WEIGHT;

EID: 0031949305     PISSN: 07351631     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-993904     Document Type: Article

References (21)

1. The Canadian Preterm Labor Investigators Group. Treatment of preterm labor with the beta-adrenergic agonist ritodrine. N Engl J Med 1992;327:308-312
2. Leveno KJ, Cunningham FG. β-adrenergic agonists for preterm labor. N Engl J Med 1992;327:349-351
3. Highby K, Xenakis E M-J, Pauerstein CJ Do tocolytic agents stop premature labor? A critical and comprehensive review of efficacy and safety. Am J Obstet Gynecol 1993; 168:1247-1259.
4. King JF, Grant A, Keirse MJNC, Chalmers I. Beta-mimetics in premature labour: An overview of the randomized controlled trials. Brit J Obstet Gynecol 1988;95:211-222
5. Korenbrot CC, AAlto LH, Laros RK. The cost effectiveness of stopping preterm labor with beta-adrenergic treatment. NEJM 1984;310:691-696
6. Norton ME, Merrill J, Cooper BAB, Kuller JA, Clyman RI. Neonata; complications after the administration of indomethacin for preterm labor. NEJM 1993;329:1602-1608
7. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Lung Maturation on Perinatal Outcomes. Effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA 1995;273:415-418
8. Hannah ME. Tocolytics - More good than harm, or is it the reverse? Birth 1995;23:41-43
9. Same RS. Tocolytics: The neonatal perspective. Child 1996;23:43-45
10. Palta M, Sadek M, Gabbert D, et al. The relation of maternal complications to outcomes in very low birth weight infants in an era of changing neonatal care. Am J Perinatol 1996;13:109-114
11. Palta M, Gabbert D, Fryback D, et al. Development and validation of an index for scoring baseline respiratory disease in the very low birth weight neonate. Pediatrics 1990;86:714-721
12. ® User's Guide, Version 6, 4th ed., Vols. 1 and 2, Cary, NC: SAS Institute INC., 1989, 1789 pages.
13. Palta M, Weinstein MR, McGuinness G, et al. A population study: Mortality and morbidity after availability of surfactant therapy. Arch of Pediat Adolescent Med 1994;148: 1295-1301
14. Crowley P, Chalmers I, Keirse MJNC. The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials. Br J Obstet Gynecol 1990;97:11-25
15. Papageorgiou AN, Doray J-L, Ardila R, Kunos I. Reduction of mortality, morbidity, and respiratory distress syndrome in infants weighing less than 1000 grams by treatment with betamethasone and ritodrine. Pediatrics 1989;83: 493-497
16. Wright LL, Horbat JD, Gunkel H, Verter J, Younes N, Andrews EB, Long W. Evidence form multicenter networks on the current use and effectiveness of antenatal corticosteroids in low birth weight infants. Am J Obstet Gynecol 1995;173:263-269
17. Wright LL, Verter J, Younes N, Stevenson D, Fanaroff AA, Shankaran S, Ehrenkrantz RA, Donovan E. Antenatal corticosteroid administration and neonatal outcome in very low birth weight infants: The NICHD Neonatal Research Network. Am J Obstet Gynecol 1995;173:269-274
18. Maher JE, Cliver SP, Goldenberg RL, Davis RO, Cropper RL. The effect of corticosteroid therapy in the very premature infant. Am J Obstet Gynecol 1994;179:869-873
19. Atkinson MW, Goldenberg RL, Gaudier FL, Cliver SP, Nelson KG, Merkatz IR, Hauth JC. Maternal coricosteroid and tocolytic treatment and morbidity and mortality in very low birth weight infants. Am J Obstet Gynecol 1995; 173:299-305
20. Groome LJ, Goldenberg RL, Cliver SP, Davis RO, Copper RL. Neonatal periventricuiar-intraventricular hemorrhage after maternal β-sympathomimetic tocolysis. Am J Obstet Gynecol 1992;167:873-879
21. Nelson KB, Grether JK. Can magnesium sulfate reduce the risk of cerebral palsy in very low birth weight infants? Pediatrics 1995;95:263-269